Status:
COMPLETED
Deworming Against Tuberculosis
Lead Sponsor:
Linkoeping University
Collaborating Sponsors:
University of Gondar
Armauer Hansen Research Institute, Ethiopia
Conditions:
Tuberculosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate whether treatment against intestinal helminths in patients with pulmonary tuberculosis undergoing chemotherapy could improve the clinical outcome by enhanci...
Detailed Description
Mycobacterium tuberculosis causing tuberculosis (TB) is a major global public health problem. Because of increasing multi drug resistance and the long treatment period of at least six months, new ther...
Eligibility Criteria
Inclusion
- Informed and written consent to take part in the study
- Newly diagnosed pulmonary TB patients according to the WHO definitions of active tuberculosis who have a positive stool sample for helminths other than Schistosoma spp.
Exclusion
- Pregnancy
- Corticosteroid or antibiotic treatment
- Symptomatic (diarrhoea) infection caused by worm infection
- Chronic diseases or acute infectious diseases other than TB or HIV
- Stool sample positive for Schistosoma spp
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00857116
Start Date
March 1 2009
End Date
August 1 2013
Last Update
August 29 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Gondar
Gondar, Region 3, Ethiopia, Gondar, Ethiopia